LEYDI ORTEGA GUERRA: Open Payments
NPI 1326828377 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 32 payments from 11 companies in 2025. Trend: 2023 $51 · 2024 $483 · 2025 $776
Food & beverage: $725Education: $51
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 9 | $209 |
| Janssen Biotech, Inc. | 3 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $106 |
| Madrigal Pharmaceuticals | 3 | $89 |
| Aimmune Therapeutics, Inc. | 3 | $72 |
| Braintree Laboratories, Inc. | 3 | $63 |
| Intercept Pharmaceuticals, Inc. | 2 | $35 |
| Novo Nordisk Inc | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
Products named: IBSRELA, TREMFYA, REZDIFFRA, ZENPEP, ENTYVIO, EOHILIA, SUFLAVE, OCALIVA.
Industry payments across FL — which companies pay providers there.
